Wolfe Josh
- SEC CIK
- 0001830001
In the past year, 1 open-market purchase filing worth $5.00M and no sales.
Current role at each company
- EIKN Eikon Therapeutics, Inc.Director, 10% Owneras of Feb 6, 2026
- SHPW Shapeways Holdings, Inc.Director, 10% Owneras of Jun 20, 2023
- AEVA Aeva Technologies, Inc.10% Owneras of Aug 9, 2022
- SNCE Science 37 Holdings, Inc.10% Owneras of Apr 6, 2022
- MTTR Matterport, Inc.10% Owneras of Jan 21, 2022
Show 2 more companies
- RXRX Recursion Pharmaceuticals, Inc.Other: Former 10% Owneras of Dec 9, 2021
- LTCH Latch, Inc.10% Owneras of Oct 5, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $5.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$5.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wolfe Josh as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EIKN Eikon Therapeutics, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 (view filing)6:25 PM ET | Feb 4 | 2 days | Wolfe Josh and 5 othersDirector, 10% Owner | PPurchase | +277.8K | $18.00 | +$5.00M | New position138.9K after | 2 lotsDuplicate filing |
| Feb 6, 2026 (view filing) | Feb 4 | 2 days | Wolfe JoshDirector, 10% Owner | PPurchase | +277.8K | $18.00 | +$5.00M | New position138.9K after | 2 lots |